Wealth Effects’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.34M Sell
4,967
-69
-1% -$20.5K 0.48% 47
2025
Q4
$1.66M Sell
5,036
-241
-5% -$81.7K 0.52% 36
2025
Q3
$1.82M Buy
5,277
+589
+13% +$178K 0.59% 31
2025
Q2
$1.46M Buy
4,688
+591
+14% +$226K 0.55% 37
2025
Q1
$2.15M Sell
4,097
-299
-7% -$153K 0.9% 23
2024
Q4
$2.22M Sell
4,396
-30
-0.7% -$17K 0.79% 23
2024
Q3
$2.59M Sell
4,426
-1
-0% -$566 0.91% 16
2024
Q2
$2.25M Buy
4,427
+901
+26% +$442K 0.82% 20
2024
Q1
$1.74M Buy
3,526
+555
+19% +$282K 0.64% 30
2023
Q4
$1.56M Buy
2,971
+53
+2% +$28.3K 0.59% 35
2023
Q3
$1.47M Sell
2,918
-55
-2% -$27.1K 0.73% 29
2023
Q2
$1.43M Buy
2,973
+1
+0% +$489 0.63% 33
2023
Q1
$1.4M Sell
2,972
-311
-9% -$150K 0.72% 33
2022
Q4
$1.74M Sell
3,283
-300
-8% -$159K 0.99% 20
2022
Q3
$1.81M Sell
3,583
-44
-1% -$23.1K 1.11% 18
2022
Q2
$1.86M Buy
3,627
+255
+8% +$128K 1.12% 19
2022
Q1
$1.72M Buy
3,372
+1
+0% +$482 0.8% 27
2021
Q4
$1.69M Buy
+3,371
New +$1.53M 0.7% 29

Other funds holding UNH

Wealth Effects's UNH Position: Q1 2026 in Review

Wealth Effects reduced its UnitedHealth (UNH) stake by 1.4% in Q1 2026, selling an estimated $20.5K and leaving 4,967 shares worth $1.34M. The position accounts for 0.48% of the portfolio, ranked #47.

Wealth Effects first reported a position in UNH in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.59M in Q3 2024. 3,019 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

  • Wealth Effects held 4,967 shares of UnitedHealth worth $1.34M as of Q1 2026.
  • Wealth Effects sold 69 UnitedHealth shares in Q1 2026, an estimated $20.5K.
  • UnitedHealth made up 0.48% of Wealth Effects's portfolio in Q1 2026, its #47 holding.
  • Wealth Effects first reported a position in UnitedHealth in Q4 2021 and has held it in 18 quarters since.
  • Wealth Effects's UnitedHealth position peaked at $2.59M in Q3 2024.
  • 3,019 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on Wealth Effects's 13F filing for Q1 2026, filed 21 Apr 2026.